Ricardo Chaves
Executive Medical Director, Infectious Diseases at Debiopharm- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
German Full professional proficiency
-
Portuguese Native or bilingual proficiency
-
Spanish Elementary proficiency
Topline Score
Bio
Eddie Power
Ricardo and I have worked together on Medical Affairs activities related to daptomycin (Cubicin®) representing Novartis and Cubist, respectively, in the Alliance between both companies, and ensuring one joint medical strategy across the globe. Ricardo has been a fantastic partner in this very effective medical partnership – one of my best examples of successful co-leadership!
Eddie Power
Ricardo and I have worked together on Medical Affairs activities related to daptomycin (Cubicin®) representing Novartis and Cubist, respectively, in the Alliance between both companies, and ensuring one joint medical strategy across the globe. Ricardo has been a fantastic partner in this very effective medical partnership – one of my best examples of successful co-leadership!
Eddie Power
Ricardo and I have worked together on Medical Affairs activities related to daptomycin (Cubicin®) representing Novartis and Cubist, respectively, in the Alliance between both companies, and ensuring one joint medical strategy across the globe. Ricardo has been a fantastic partner in this very effective medical partnership – one of my best examples of successful co-leadership!
Eddie Power
Ricardo and I have worked together on Medical Affairs activities related to daptomycin (Cubicin®) representing Novartis and Cubist, respectively, in the Alliance between both companies, and ensuring one joint medical strategy across the globe. Ricardo has been a fantastic partner in this very effective medical partnership – one of my best examples of successful co-leadership!
Credentials
-
German Full Licensure for Practice of Medicine (Approbation)
Hessisches Landespruefungsamt fuer HeilberufeJan, 2000- Nov, 2024 -
Board Certification - Specialist in Microbiology and Epidemiology of Infectious Diseases, Facharzt
German Medical Council, Berlin (Aerztekammer Berlin)Jan, 1999- Nov, 2024 -
PhD Degree, Dr.rer.nat
Eberhard-Karls-Universität Tübingen and Universität BremenJan, 1996- Nov, 2024 -
Board Certification - Specialist in Infectious and Parasitic Diseases
Brazilian Ministry of Health, Institute for Infectious Diseases Emilio Ribas -
Brazilian Full Licensure for Practice of Medicine, Medico
Brazilian Ministry of Education -
MD Degree
Federal University of Rio de Janeiro (UFRJ) -
Specialist in Tropical Medicine
University of Sao Paulo, Institute for Tropical Medicine
Experience
-
Debiopharm
-
Switzerland
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Executive Medical Director, Infectious Diseases
-
Mar 2021 - Present
Medical Leadership with commitment to improve outcomes and quality of life of patients with infectious diseases, to deliver optimal strategy for drug development in areas with high unmet need and to deliver tomorrow's standard of care. - Design and lead the clinical strategy and the clinical development plan of company compounds related to infectious diseases. Support Human Resources in hiring activities and talent development - Responsible for Clinical Development Plan and the… Show more Medical Leadership with commitment to improve outcomes and quality of life of patients with infectious diseases, to deliver optimal strategy for drug development in areas with high unmet need and to deliver tomorrow's standard of care. - Design and lead the clinical strategy and the clinical development plan of company compounds related to infectious diseases. Support Human Resources in hiring activities and talent development - Responsible for Clinical Development Plan and the clinical/medical input on the Target Product Profile (TPP) and taking into account relevant business constraints - Ensure optimal development at the medical and clinical levels to leverage the project value in partnership with the project team and with a network of internal/external experts, key investigators, institutions, medical associations and symposia - Identify and address scientific needs and stay abreast of current scientific trends - Develop, review, and revise protocols, CRF, training materials, data tables, listing and figures with the support of the Clinical Trial Teams/scientists - Responsible for the preparation of the clinical section of regulatory documents - Generate and/or review publications, posters, and scientific presentations - Responsible for medical and safety monitoring and medical data review - Support the Evaluation department in the evaluation of New Opportunities and draft its clinical development plan - Provide medical leadership in all grant requests for clinical and pre-clinical development compounds Show less Medical Leadership with commitment to improve outcomes and quality of life of patients with infectious diseases, to deliver optimal strategy for drug development in areas with high unmet need and to deliver tomorrow's standard of care. - Design and lead the clinical strategy and the clinical development plan of company compounds related to infectious diseases. Support Human Resources in hiring activities and talent development - Responsible for Clinical Development Plan and the… Show more Medical Leadership with commitment to improve outcomes and quality of life of patients with infectious diseases, to deliver optimal strategy for drug development in areas with high unmet need and to deliver tomorrow's standard of care. - Design and lead the clinical strategy and the clinical development plan of company compounds related to infectious diseases. Support Human Resources in hiring activities and talent development - Responsible for Clinical Development Plan and the clinical/medical input on the Target Product Profile (TPP) and taking into account relevant business constraints - Ensure optimal development at the medical and clinical levels to leverage the project value in partnership with the project team and with a network of internal/external experts, key investigators, institutions, medical associations and symposia - Identify and address scientific needs and stay abreast of current scientific trends - Develop, review, and revise protocols, CRF, training materials, data tables, listing and figures with the support of the Clinical Trial Teams/scientists - Responsible for the preparation of the clinical section of regulatory documents - Generate and/or review publications, posters, and scientific presentations - Responsible for medical and safety monitoring and medical data review - Support the Evaluation department in the evaluation of New Opportunities and draft its clinical development plan - Provide medical leadership in all grant requests for clinical and pre-clinical development compounds Show less
-
-
-
Novartis
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Global Director Medical & Scientific Excellence - Novartis Pharma
-
2019 - 2021
I have played a key role as medical reviewer & approver at the Global Labelling Committee to manage Novartis pharmaceutical product labelling functions. I've delivered high-quality medical and scientific leadership while implementing knowledge programs applicable to worldwide roles in our department worldwide. • Provided Medical oversight of the whole Novartis portfolio, including small molecules, biologics, cell- and gene therapy from Oncology and General Medicines/Pharma, with… Show more I have played a key role as medical reviewer & approver at the Global Labelling Committee to manage Novartis pharmaceutical product labelling functions. I've delivered high-quality medical and scientific leadership while implementing knowledge programs applicable to worldwide roles in our department worldwide. • Provided Medical oversight of the whole Novartis portfolio, including small molecules, biologics, cell- and gene therapy from Oncology and General Medicines/Pharma, with responsibility for Global label approval and ensuring medical and scientific excellence for both pipeline and approved products. • Introduced new procedures for defining transformative capability needs and training offerings on medical and launch excellence of 2000 medical associates worldwide
-
-
Global Program Medical Director/Global Brand Medical Director, Clinical Development &Medical Affairs
-
2007 - 2019
2007-2011 Global Medical Director, CD&MA: I've delivered leadership to build new clinical development team to prepare clinical documents and regulatory dossiers, global launch, market access and commercialization of daptomycin in adults and children. • Led the clinical team to obtain global regulatory approval for daptomycin in skin infections-bacteremia-endocarditis (+label extensions) and to prepare&execute its global launch • Delivered Ph 1 to 4 trials, study reports, drug safety… Show more 2007-2011 Global Medical Director, CD&MA: I've delivered leadership to build new clinical development team to prepare clinical documents and regulatory dossiers, global launch, market access and commercialization of daptomycin in adults and children. • Led the clinical team to obtain global regulatory approval for daptomycin in skin infections-bacteremia-endocarditis (+label extensions) and to prepare&execute its global launch • Delivered Ph 1 to 4 trials, study reports, drug safety documents, publications/communications, as well as partnerships with medical societies to improve clinical practice • Business Development: Key point person in the collaboration with Cubist ensuring one joint strategy for daptomycin worldwide, blockbuster status. 2011-2019 Global Brand Medical Director, GMA: I've played key role to build the new GMA department. I've recruited and developed Medical teams in 3 Global Franchises. I've provided medical leadership, created/implemented medical strategy for pipeline products + mature portfolio in neurology, psychiatry, infectious diseases and pain management. I've implemented best practices in clinical trials, launch of new products / of new indications for established products. I've created medical plans and product strategy plans ensuring digitalisation of medical activities and education as well as excellence in communications/publications. • Delivered people leadership, medical budget accountability and management of portfolio of products with $2.5B annual sales • Implemented global medical launch of 15cm2 rivastigmine patch in dementia (80+ countries) + launch preparation for AFQ056 in Fragile X syndrome • Delivered first launch of rivastigmine patch in Alzheimer’s dementia in Japan and China • Implemented global launch of methylphenidate in the new indication Adult ADHD • Strengthened collaboration with medical associations/Tier 1 experts to improve outcomes in epilepsy, Parkinson’s disease, multiple sclerosis and painful conditions
-
-
-
Boehringer Ingelheim
-
Germany
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Section Head Immunology & Virology, Team Member Medicine
-
2002 - 2007
I have delivered medical leadership of development projects for antiviral drugs with responsibilities for the Global organization and for the local Pharma organization in Germany. Core global responsibilities in Hep C and HIV. Clinical Development Plans, definition of PK/PD targets and target product profile in close collaboration with Pre-Clinical Research and Pharma functions. First protease inhibitors for Hepatitis C Virus (BILN-2061) in Phase I and Phase II and first study in man with… Show more I have delivered medical leadership of development projects for antiviral drugs with responsibilities for the Global organization and for the local Pharma organization in Germany. Core global responsibilities in Hep C and HIV. Clinical Development Plans, definition of PK/PD targets and target product profile in close collaboration with Pre-Clinical Research and Pharma functions. First protease inhibitors for Hepatitis C Virus (BILN-2061) in Phase I and Phase II and first study in man with back-up PI BI201335. Phase II and successful pivotal Ph III trials with HIV Protease Inhibitor Tipranavir (Aptivus®), including launch. Show less I have delivered medical leadership of development projects for antiviral drugs with responsibilities for the Global organization and for the local Pharma organization in Germany. Core global responsibilities in Hep C and HIV. Clinical Development Plans, definition of PK/PD targets and target product profile in close collaboration with Pre-Clinical Research and Pharma functions. First protease inhibitors for Hepatitis C Virus (BILN-2061) in Phase I and Phase II and first study in man with… Show more I have delivered medical leadership of development projects for antiviral drugs with responsibilities for the Global organization and for the local Pharma organization in Germany. Core global responsibilities in Hep C and HIV. Clinical Development Plans, definition of PK/PD targets and target product profile in close collaboration with Pre-Clinical Research and Pharma functions. First protease inhibitors for Hepatitis C Virus (BILN-2061) in Phase I and Phase II and first study in man with back-up PI BI201335. Phase II and successful pivotal Ph III trials with HIV Protease Inhibitor Tipranavir (Aptivus®), including launch. Show less
-
-
-
Chiron Vaccines, Chiron Behring GmbH & Co. KG
-
Marburg, Germany
-
Section Head Vaccines, Clinical Team Leader International Projects
-
1999 - 2002
I have delivered clinical leadership in the development of new vaccines. Global Medical Leader in the early development of new Influenza vaccine produced in cell lines (MDCK). Global Medical Leader for pivotal Phase III trials for yearly approval of flu vaccine produced in eggs (Begrivac®). Medical Leader for cell-culture vaccines plus novel adjuvant MF59. Clinical Development Plan and Budget Planning. Clinical Dossiers and Safety Updates for regulatory authorities. Medical Affairs Leadership… Show more I have delivered clinical leadership in the development of new vaccines. Global Medical Leader in the early development of new Influenza vaccine produced in cell lines (MDCK). Global Medical Leader for pivotal Phase III trials for yearly approval of flu vaccine produced in eggs (Begrivac®). Medical Leader for cell-culture vaccines plus novel adjuvant MF59. Clinical Development Plan and Budget Planning. Clinical Dossiers and Safety Updates for regulatory authorities. Medical Affairs Leadership and Phase IV trials with cell-culture vaccine against Rabies (Rabipur®). Show less I have delivered clinical leadership in the development of new vaccines. Global Medical Leader in the early development of new Influenza vaccine produced in cell lines (MDCK). Global Medical Leader for pivotal Phase III trials for yearly approval of flu vaccine produced in eggs (Begrivac®). Medical Leader for cell-culture vaccines plus novel adjuvant MF59. Clinical Development Plan and Budget Planning. Clinical Dossiers and Safety Updates for regulatory authorities. Medical Affairs Leadership… Show more I have delivered clinical leadership in the development of new vaccines. Global Medical Leader in the early development of new Influenza vaccine produced in cell lines (MDCK). Global Medical Leader for pivotal Phase III trials for yearly approval of flu vaccine produced in eggs (Begrivac®). Medical Leader for cell-culture vaccines plus novel adjuvant MF59. Clinical Development Plan and Budget Planning. Clinical Dossiers and Safety Updates for regulatory authorities. Medical Affairs Leadership and Phase IV trials with cell-culture vaccine against Rabies (Rabipur®). Show less
-
-
-
Humboldt-Universität zu Berlin
-
Germany
-
Higher Education
-
700 & Above Employee
-
Physician, Scientific Officer
-
1996 - 1999
Clinical virology & clinical microbiology, laboratory diagnosis, counseling and treatment recommendations concerning infectious diseases for all clinics of the medical school. Clinical studies. Lectures and Seminars for medical students Clinical virology & clinical microbiology, laboratory diagnosis, counseling and treatment recommendations concerning infectious diseases for all clinics of the medical school. Clinical studies. Lectures and Seminars for medical students
-
-
-
University of Tübingen
-
Higher Education
-
700 & Above Employee
-
Medical Research & Scientific Officer
-
1991 - 1996
Research in viral hepatitis A-G, including completion of PhD thesis in Pathogenesis of Hepatitis A, magna cum laude. Laboratory work in diagnostics of viral diseases for patients from all clinics or research purposes with conventional and molecular biology methods. Clinical trials with vaccines including first immunogenic hepatitis A vaccine for humans ( later marketed by Pasteur-Merieux/Aventis) Research in viral hepatitis A-G, including completion of PhD thesis in Pathogenesis of Hepatitis A, magna cum laude. Laboratory work in diagnostics of viral diseases for patients from all clinics or research purposes with conventional and molecular biology methods. Clinical trials with vaccines including first immunogenic hepatitis A vaccine for humans ( later marketed by Pasteur-Merieux/Aventis)
-
-
-
-
Physician, Primary Care Unit
-
Apr 1989 - Dec 1990
Ambulatory for primary care, family medicine and medical emergency care for low-income population in the periphery of Sao Paulo City Ambulatory for primary care, family medicine and medical emergency care for low-income population in the periphery of Sao Paulo City
-
-
-
-
Physician, HIV/AIDS Ward
-
May 1988 - Dec 1990
Physician at Unit for AIDS and Hemophilia. Patient management and treatment of HIV/AIDS and hemophilia. Physician at Unit for AIDS and Hemophilia. Patient management and treatment of HIV/AIDS and hemophilia.
-
-
-
-
Resident Physician, Attending Physician
-
Feb 1987 - Dec 1990
Internal Medicine including Critical Care and Emergencies in Infectious Diseases and Tropical Medicine. Medical management and treatment of in- and out-patients in a National Center for Infectious Diseases. Seminars for medical students. After completion of the Medical Residency I was promoted to Assistant Physician Internal Medicine including Critical Care and Emergencies in Infectious Diseases and Tropical Medicine. Medical management and treatment of in- and out-patients in a National Center for Infectious Diseases. Seminars for medical students. After completion of the Medical Residency I was promoted to Assistant Physician
-
-
Education
-
University of Tuebingen
PhD, Dr.rer.nat, Virology -
1986 -
Federal University of Rio de Janeiro
Doctor of Medicine - MD, Medicine
Community
